[1]
Cheng, Y. 2025. The Valuation and Strategic Role of Amgen as an Anchor Stock in the Biopharmaceutical Industry Under Market Volatility. Journal of Innovation and Development. 13, 1 (Nov. 2025), 294–300. DOI:https://doi.org/10.54097/am35dd94.